Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 48.99% is 83% above its 5-year average of 26.77%, near the high end of its 5-year range (10.53%–48.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.84% above its 12-month average of 43.81%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 48.99%.
DEBT TO ASSETS RATIO
48.99%
DEBT TO ASSETS RATIO AVG TTM
43.81%
DEBT TO ASSETS RATIO AVG 3Y
34.68%
DEBT TO ASSETS RATIO AVG 5Y
26.77%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.84%
CURRENT VS 3Y AVG
+41.28%
CURRENT VS 5Y AVG
+83.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 839 covered companies
CURRENT VS SECTOR MEDIAN
+54337.01%
vs the sector median at left
Pulmonx Corporation
Market Cap
$77.08M
Debt to Assets Ratio
48.99%
TTM Avg
43.81%
3Y Avg
34.68%
5Y Avg
26.77%
Market Cap
$77.15M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.14M
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.05M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.07M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.96M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $77.08M | 48.99% | 43.81% | 34.68% | 26.77% |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 0.03% | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.64M | 0.21% | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.22M | 0.43% | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | 0.75% | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.05M | 0.06% | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | 0.16% | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | 0.09% | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $80.11M | 0.03% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | 0.02% | N/A | N/A | N/A |
Debt/Assets
49.0%
Debt/Equity
1.43
Current Ratio
4.32
Interest Coverage
-17.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 48.99% |
| 2026-03-31 | 46.92% |
| 2025-12-31 | 43.59% |
| 2025-09-30 | 40.91% |
| 2025-06-30 | 38.61% |
| 2025-03-31 | 37.78% |
| 2024-12-31 | 34.68% |
| 2024-09-30 | 33.73% |
| 2024-06-30 | 32.55% |
| 2024-03-31 | 24.65% |
| 2023-12-31 | 23.30% |
| 2023-09-30 | 22.82% |
| 2023-06-30 | 22.26% |
| 2023-03-31 | 21.65% |
| 2022-12-31 | 12.57% |
| 2022-09-30 | 12.45% |
| 2022-06-30 | 16.14% |
| 2022-03-31 | 15.98% |
| 2021-12-31 | 11.25% |
| 2021-09-30 | 10.85% |
| 2021-06-30 | 10.53% |
| 2021-03-31 | 10.50% |
| 2020-12-31 | 10.32% |
| 2020-09-30 | 80.33% |
| 2020-06-30 | 391.97% |
| 2019-12-31 | 424.32% |
